Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men.
Hannawi S, Saf Eldin L, Abuquta A, Alamadi A, Mahmoud SA, Hassan A, Xu S, Li J, Liu D, Baidoo AAH, Ibrahim D, Alhaj M, Chen Y, Zhou Q, Xie L.
Hannawi S, et al.
Nat Commun. 2023 Jul 8;14(1):4043. doi: 10.1038/s41467-023-39766-x.
Nat Commun. 2023.
PMID: 37422518
Free PMC article.